Abstract |
The ability of parbendazole (PBZ) to potentiate co-administered oxfendazole (OFZ) was investigated. Administration of a range (1.35-36.0 mg/kg) of doses of PBZ with 4.53 mg OFZ/kg demonstrated that significant potentiation occurred at 4.5 mg PBZ/kg. At 4.5 mg PBZ/kg, the area under the plasma OFZ concentration curve was about twice that obtained from oral administration of OFZ alone. When tested against benzimidazole-resistant Haemonchus contortus and Trichostrongylus colubriformis, the mixture of 4.5 mg PBZ + 4.53 mg OFZ/kg was significantly more effective than 4.53 mg OFZ/kg alone, and PBZ alone showed no activity against these resistant nematodes. The demonstration of PBZ-OFZ potentiation has indicated a means of obtaining a more effective use of currently available anthelmintics in the treatment of helminthiasis.
|
Authors | D R Hennessy, E Lacey, R K Prichard, J W Steel |
Journal | Journal of veterinary pharmacology and therapeutics
(J Vet Pharmacol Ther)
Vol. 8
Issue 3
Pg. 270-5
(Sep 1985)
ISSN: 0140-7783 [Print] England |
PMID | 3840535
(Publication Type: Journal Article)
|
Chemical References |
- Anthelmintics
- Benzimidazoles
- parbendazole
- oxfendazole
|
Topics |
- Animals
- Anthelmintics
(pharmacology)
- Benzimidazoles
(blood, pharmacology, therapeutic use)
- Chromatography, High Pressure Liquid
- Drug Synergism
- Kinetics
- Male
- Nematode Infections
(drug therapy, veterinary)
- Plasma
(metabolism)
- Sheep
(blood)
- Sheep Diseases
(drug therapy)
|